Other

Noncontrolling interests in subsidiaries

Elevance Health Noncontrolling interests in subsidiaries decreased by 2.8% to $140.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.7%, from $117.00M to $140.00M.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026

How to read this metric

Fluctuations reflect changes in the profitability of partially owned subsidiaries or changes in ownership percentages.

Detailed definition

This represents the portion of equity in a subsidiary that is not attributable to the parent company. It reflects the ow...

Peer comparison

Common in mining companies that operate through joint ventures or regional subsidiaries.

Metric ID: other_minority_interest

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$78.00M$71.00M$68.00M$56.00M$55.00M$52.00M$87.00M$104.00M$107.00M$116.00M$99.00M$102.00M$106.00M$104.00M$111.00M$117.00M$129.00M$129.00M$144.00M$140.00M
QoQ Change-9.0%-4.2%-17.6%-1.8%-5.5%+67.3%+19.5%+2.9%+8.4%-14.7%+3.0%+3.9%-1.9%+6.7%+5.4%+10.3%+0.0%+11.6%-2.8%
YoY Change-29.5%-26.8%+27.9%+85.7%+94.5%+123.1%+13.8%-1.9%-0.9%-10.3%+12.1%+14.7%+21.7%+24.0%+29.7%+19.7%
Range$52.00M$144.00M
CAGR+13.1%
Avg YoY Growth+24.8%
Median YoY Growth+17.2%

Noncontrolling interests in subsidiaries at Other Companies

Frequently Asked Questions

What is Elevance Health's noncontrolling interests in subsidiaries?
Elevance Health (ELV) reported noncontrolling interests in subsidiaries of $140.00M in Q1 2026.
How has Elevance Health's noncontrolling interests in subsidiaries changed year-over-year?
Elevance Health's noncontrolling interests in subsidiaries increased by 19.7% year-over-year, from $117.00M to $140.00M.
What does noncontrolling interests in subsidiaries mean?
The share of a subsidiary's value that belongs to other investors rather than the parent company.